Articles

CBA Members

Propriété
intellectuelle

Section du droit de la propriété intellectuelle de l’ABC

Les articles de la Section du droit de la propriĂ©tĂ© intellectuelle de l’ABC sont publiĂ©s par la Section du droit de la propriĂ©tĂ© intellectuelle. Les membres qui souhaitent proposer des articles sont invitĂ©s Ă  les envoyer Ă  la section Ă  : droitproprieteintellectuelleABC@cba.org.

AujourdĘĽhui
AujourdĘĽhui

Case summary: Law to be applied in evidentiary issues

  • 30 octobre 2023
  • Cheryl Cheung

The plaintiff, Fromfroid S.A., sued the defendants, 1048547 Ontario Inc. (better known as Skotidakis) and Frimasco Inc., for infringing Fromfroid’s Canadian Patent No. 2,301,753.

Propriété intellectuelle

Case summary: Costs award in patent infringement case

  • 30 octobre 2023
  • Cheryl Cheung

These reasons related to a decision on costs following a patent infringement judgment (citation: 2023 FC 925). In the main action, the plaintiff, Fromfroid S.A., prevailed and was awarded regular and punitive damages against the defendants,1048547 Ontario Inc. (better known as Skotidakis) and Frimasco Inc.

Propriété intellectuelle

Case summary: Intellectual property proceedings do not always entitle parties to elevated costs awards under Rule 407 of the Federal Court Rules

  • 23 aoĂ»t 2023
  • Eric Li

This decision was an assessment of costs arising from Zara Natural Stones Inc.’s (“Zara”) successful appeal before the Federal Court of Appeal. The Assessment Officer applied Rule 407 of the Federal Courts Rules (“Rules”) and assessed costs in accordance with Column III of the table to Tariff B.

Propriété intellectuelle

Case summary: Federal Court grants application to add inventor

  • 23 aoĂ»t 2023
  • Eric Li

This case involved Regeneron Pharmaceuticals, Inc.’s (“Regeneron”) application pursuant to s 52 of the Patent Act (“Act”) to vary the records concerning the registration for their patent so as to name an additional inventor.

Propriété intellectuelle

Case summary: Federal Court refuses motion to compel answers to questions objected to during examination for discovery

  • 23 aoĂ»t 2023
  • Eric Li

This case involved a proceeding pursuant to s 6 of the Patented Medicines (Notice of Compliance) Regulations. Allergan, Inc. (“Allergan”) brought a motion pursuant to Rule 97 of the Federal Courts Rules to compel answers to questions that were objected to during examination for discovery of one of Juno Pharmaceuticals Corp.’s (“Juno”) fact witnesses. Allergan grouped these questions under four categories, A, B, C, and D.

Propriété intellectuelle

Case summary: Assessment and awarding of costs and disbursements arising from a trademark validity dispute

  • 23 aoĂ»t 2023
  • Michael Mitchell

This decision was an assessment of costs. In the underlying decision, the Federal Court (“Court”) assessed Travel Leaders Group’s claims of invalidity on the basis of material misstatement as to the date of first use, abandonment and bad faith under ss 18(1)(a), (c), and (e) of the Trademarks Act, respectively.

Propriété intellectuelle

Case summary: Evidence of exceptional and unforeseen circumstances required for motions to adjourn under Rule 36 of the Federal Courts Rules

  • 23 aoĂ»t 2023
  • Eric Li

This decision concerned a motion by the Plaintiffs under Rule 36 of the Federal Courts Rules to request a six-month adjournment of the trial of the underlying trademark action. The Plaintiffs requested the adjournment on the basis that its recently retained expert witness needed additional time to prepare her report.

Propriété intellectuelle